Search Results for: Marc Tessier-Lavigne

Weekly reads: Marc Tessier-Lavigne probe, Neuralink on the brain, Ras unchained

/ / Leave a Comment
Marc Tessier-Lavigne

We’ll start with a story related to possible research misconduct, Stanford’s President Marc Tessier-Lavigne, and Science Magazine.  In some ways the news on Science itself could be the bigger long-term story. Marc Tessier-Lavigne pub investigation, Science oops moment Here’s some of the coverage: Stanford investigates potential misconduct in president’s research, Science. Multiple publications of Marc Tessier-Lavigne […]

Weekly reads: Marc Tessier-Lavigne probe, Neuralink on the brain, Ras unchained Read More »

Recommended reads: John Cleese, surprising human embryo study, stem bank scandal, reprogramming & aging

/ / Leave a Comment
John Cleese stem cells anti-aging, John Cleese

If you remember Monty Python, then you probably recall John Cleese. We’ll start with Cleese’s stem cell baloney. Not spam. Secret to eternal youth? John Cleese extols virtues of stem cell treatment, The Guardian. I’ve written before about John Cleese’s stem cell anti-aging efforts. As I told the author of The Guardian piece, I love

Recommended reads: John Cleese, surprising human embryo study, stem bank scandal, reprogramming & aging Read More »

Perspectives 10 years after STAP cells: the culture of science, misconduct, & hopes for progress

/ / 6 Comments
Haruko-Obokata-小保方-晴子-

Exactly ten years ago today, on January 29, 2014, I wrote about two new Nature papers on so-called STAP cells. The papers claimed that stress alone could convert regular non-stem cells into some of the most powerful stem cells. More specifically, the authors claimed to make pluripotent stem cells similar to iPS cells this way.

Perspectives 10 years after STAP cells: the culture of science, misconduct, & hopes for progress Read More »

Weekly reads: BioCardia, HeLa suit, illegal bio lab in CA

/ / Leave a Comment
mesenchymal cells

A days ago the news came about Mesoblast not getting FDA approval for its MSC product for GvHD. The MSC area has had a rough few years with various clinical trials including for COVID. The “stem cells for heart disease” arena has also had a tough time. Here’s more news along these lines: BioCardia pauses enrollment in PhIII trial

Weekly reads: BioCardia, HeLa suit, illegal bio lab in CA Read More »

Weekly reads: Conception Bio & IVG, MYC, Stanford Prez resigns

/ / Leave a Comment
Conception Bio, IVG

The Bay Area biotech Conception Bio has an intriguing name. What does “conception” mean here? Scientists can make many things from stem cells. For example, lately I’ve written a lot about stem cell-based human embryo models. Another intriguing area is called in vitro gametogenesis or IVG, where Conception Bio is a leader. IVG means making

Weekly reads: Conception Bio & IVG, MYC, Stanford Prez resigns Read More »

Trends in retractions as AI arms race on misconduct looms

/ / 3 Comments
stem cell paper retractions, retraction watch

There has been a big jump in paper retractions in science over the last 20 years. What’s going on? How do the trends in the stem cell field compare to other fields like cancer research and more broadly? Is AI going to change the dynamic between those engaging in misconduct and those who are looking for misconduct

Trends in retractions as AI arms race on misconduct looms Read More »